SG11201610456UA - Influenza virus vaccines and uses thereof - Google Patents
Influenza virus vaccines and uses thereofInfo
- Publication number
- SG11201610456UA SG11201610456UA SG11201610456UA SG11201610456UA SG11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA SG 11201610456U A SG11201610456U A SG 11201610456UA
- Authority
- SG
- Singapore
- Prior art keywords
- influenza virus
- virus vaccines
- vaccines
- influenza
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14176459 | 2014-07-10 | ||
| US201462062754P | 2014-10-10 | 2014-10-10 | |
| EP14195143 | 2014-11-27 | ||
| EP15155761 | 2015-02-19 | ||
| PCT/EP2015/065663 WO2016005482A1 (en) | 2014-07-10 | 2015-07-09 | Influenza virus vaccines and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201610456UA true SG11201610456UA (en) | 2017-01-27 |
Family
ID=55063616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201610456UA SG11201610456UA (en) | 2014-07-10 | 2015-07-09 | Influenza virus vaccines and uses thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10117925B2 (en) |
| EP (1) | EP3166963B1 (en) |
| JP (1) | JP7094103B2 (en) |
| KR (1) | KR102463632B1 (en) |
| CN (1) | CN107074912B (en) |
| AU (1) | AU2015286723B2 (en) |
| BR (1) | BR112016030577A8 (en) |
| CA (1) | CA2953451C (en) |
| CL (1) | CL2017000064A1 (en) |
| EA (1) | EA035375B1 (en) |
| MX (1) | MX2017000395A (en) |
| MY (1) | MY182440A (en) |
| PE (1) | PE20170291A1 (en) |
| PH (1) | PH12016502468B1 (en) |
| SG (1) | SG11201610456UA (en) |
| WO (1) | WO2016005482A1 (en) |
| ZA (1) | ZA201700165B (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2787099A1 (en) | 2009-03-30 | 2010-10-14 | Anice C. Lowen | Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof |
| SG11201402633UA (en) | 2011-11-28 | 2014-09-26 | Crucell Holland Bv | Influenza virus vaccines and uses thereof |
| NZ627796A (en) | 2012-12-18 | 2017-07-28 | Icahn School Med Mount Sinai | Influenza virus vaccines and uses thereof |
| WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
| CA2913859C (en) | 2013-05-30 | 2021-11-30 | Crucell Holland B.V. | Influenza virus vaccines and uses thereof |
| BR112017000257A2 (en) | 2014-07-10 | 2017-10-31 | Janssen Vaccines & Prevention Bv | influenza vaccines and their uses |
| JP2018504412A (en) | 2015-01-23 | 2018-02-15 | アイカーン スクール オブ メディシン アット マウント サイナイ | Influenza virus vaccination regimen |
| US11266734B2 (en) | 2016-06-15 | 2022-03-08 | Icahn School Of Medicine At Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
| CN110167585B (en) * | 2016-09-02 | 2024-03-08 | 美国卫生与公众服务部 | Stabilized group 2 influenza hemagglutinin stem trimer and uses thereof |
| WO2018187706A2 (en) | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
| CN107765001B (en) * | 2017-10-24 | 2020-03-27 | 中国科学院苏州纳米技术与纳米仿生研究所 | Kit for immunizing and typing avian influenza virus infection or avian influenza vaccine |
| HRP20220980T1 (en) | 2018-01-23 | 2022-11-11 | Janssen Vaccines & Prevention B.V. | Influenza virus vaccines and uses thereof |
| WO2019191257A1 (en) * | 2018-03-28 | 2019-10-03 | Sanofi Pasteur Inc. | Methods of generating broadly protective vaccine compositions comprising hemagglutinin |
| EP3814507A4 (en) * | 2018-06-27 | 2022-07-06 | Medicago Inc. | Influenza virus hemagglutinin mutants |
| CN109239355B (en) * | 2018-09-05 | 2020-08-25 | 中牧实业股份有限公司 | Enzyme-linked immunoassay kit for avian influenza virus H9 subtype antibody |
| WO2020061443A2 (en) * | 2018-09-21 | 2020-03-26 | Board Of Regents Of The University Of Nebraska | Methods of making and using universal centralized influenza vaccine genes |
| CA3152957A1 (en) * | 2019-09-05 | 2021-03-11 | Janssen Vaccines & Prevention B.V. | Influenza virus vaccines and uses thereof |
| GB202004825D0 (en) * | 2020-04-01 | 2020-05-13 | Diosynvax Ltd | Influenza vaccines |
| JP2023539771A (en) * | 2020-09-07 | 2023-09-19 | インターベット インターナショナル ベー． フェー． | HA stem vaccine for HA antibody positive targets |
| TW202317600A (en) * | 2021-06-23 | 2023-05-01 | 潤惠生技股份有限公司 | Multivalent vaccine for protection against multiple virus infection |
| WO2023154821A2 (en) * | 2022-02-11 | 2023-08-17 | University Of Washington | Compositions comprising influenza hemagglutinin stem and method for enhancing cross-protective immunity |
| WO2023198815A1 (en) | 2022-04-14 | 2023-10-19 | Janssen Vaccines & Prevention B.V. | Sequential administration of adenoviruses |
| WO2024104947A2 (en) * | 2022-11-14 | 2024-05-23 | Janssen Vaccines & Prevention B.V. | Influenza b virus vaccines and uses thereof |
| CN116589566A (en) * | 2022-11-18 | 2023-08-15 | 昆明医科大学第一附属医院 | Modified recombinant monoclonal IgM antibody of HIV-1 neutralizing antibody and application thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY170607A (en) * | 2006-09-07 | 2019-08-20 | Crucell Holland Bv | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| CA2787099A1 (en) * | 2009-03-30 | 2010-10-14 | Anice C. Lowen | Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof |
| BRPI1012749B1 (en) | 2009-05-11 | 2022-01-11 | Janssen Vaccines & Prevention B.V. | HUMAN MONOCLONAL ANTIBODY, ITS USE AND PRODUCTION METHOD, IMMUNOCONJUGATE, AND PHARMACEUTICAL COMPOSITION |
| CA2792537A1 (en) * | 2010-03-30 | 2011-10-06 | Mount Sinai School Of Medicine | Influenza virus vaccines and uses thereof |
| WO2012054745A1 (en) * | 2010-10-20 | 2012-04-26 | New York Blood Center, Inc. | Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection |
| MX346206B (en) | 2011-07-14 | 2017-03-09 | Crucell Holland Bv | Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses. |
| SG11201402633UA (en) * | 2011-11-28 | 2014-09-26 | Crucell Holland Bv | Influenza virus vaccines and uses thereof |
| CA2913859C (en) | 2013-05-30 | 2021-11-30 | Crucell Holland B.V. | Influenza virus vaccines and uses thereof |
| BR112017000257A2 (en) | 2014-07-10 | 2017-10-31 | Janssen Vaccines & Prevention Bv | influenza vaccines and their uses |
-
2015
- 2015-07-09 CN CN201580037387.0A patent/CN107074912B/en active Active
- 2015-07-09 AU AU2015286723A patent/AU2015286723B2/en active Active
- 2015-07-09 MY MYPI2017700047A patent/MY182440A/en unknown
- 2015-07-09 MX MX2017000395A patent/MX2017000395A/en unknown
- 2015-07-09 EP EP15738028.8A patent/EP3166963B1/en active Active
- 2015-07-09 US US15/324,939 patent/US10117925B2/en active Active
- 2015-07-09 WO PCT/EP2015/065663 patent/WO2016005482A1/en active Application Filing
- 2015-07-09 SG SG11201610456UA patent/SG11201610456UA/en unknown
- 2015-07-09 BR BR112016030577A patent/BR112016030577A8/en not_active Application Discontinuation
- 2015-07-09 EA EA201692467A patent/EA035375B1/en not_active IP Right Cessation
- 2015-07-09 PE PE2017000043A patent/PE20170291A1/en unknown
- 2015-07-09 KR KR1020177003528A patent/KR102463632B1/en active IP Right Grant
- 2015-07-09 JP JP2017500875A patent/JP7094103B2/en active Active
- 2015-07-09 CA CA2953451A patent/CA2953451C/en active Active
-
2016
- 2016-12-12 PH PH12016502468A patent/PH12016502468B1/en unknown
-
2017
- 2017-01-09 ZA ZA2017/00165A patent/ZA201700165B/en unknown
- 2017-01-10 CL CL2017000064A patent/CL2017000064A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7094103B2 (en) | 2022-07-01 |
| CA2953451C (en) | 2023-09-19 |
| PH12016502468A1 (en) | 2017-04-10 |
| JP2017521073A (en) | 2017-08-03 |
| MY182440A (en) | 2021-01-25 |
| CL2017000064A1 (en) | 2017-11-10 |
| EA035375B1 (en) | 2020-06-03 |
| KR20170027846A (en) | 2017-03-10 |
| EA201692467A1 (en) | 2017-05-31 |
| PE20170291A1 (en) | 2017-03-26 |
| AU2015286723B2 (en) | 2019-11-21 |
| ZA201700165B (en) | 2019-06-26 |
| EP3166963A1 (en) | 2017-05-17 |
| MX2017000395A (en) | 2018-02-08 |
| CA2953451A1 (en) | 2016-01-14 |
| KR102463632B1 (en) | 2022-11-03 |
| BR112016030577A8 (en) | 2021-07-20 |
| BR112016030577A2 (en) | 2017-10-31 |
| US20170189519A1 (en) | 2017-07-06 |
| EP3166963B1 (en) | 2020-04-22 |
| US10117925B2 (en) | 2018-11-06 |
| CN107074912B (en) | 2021-10-29 |
| AU2015286723A1 (en) | 2017-01-12 |
| PH12016502468B1 (en) | 2017-04-10 |
| CN107074912A (en) | 2017-08-18 |
| WO2016005482A1 (en) | 2016-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
| HK1255847A1 (en) | Vaccines against hepatitis b virus | |
| SG10201913630YA (en) | Zika virus vaccine | |
| RS63381B1 (en) | Respiratory virus vaccines | |
| HK1246183A1 (en) | Hpv vaccines | |
| SI3393510T1 (en) | Zika virus vaccine | |
| ZA201700952B (en) | Indoles for use in influenza virus infection | |
| IL286265A (en) | Novel tilapia virus and uses thereof | |
| SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
| HK1223110A1 (en) | Influenza virus vaccines and uses thereof | |
| EP3119883A4 (en) | Influenza virus vectors and uses therefor | |
| GB201613191D0 (en) | Zika virus vaccine | |
| HK1254344A1 (en) | Antigenically matched influenza vaccines | |
| SG11201702116VA (en) | Viral rna segments as immunomodulatory agents and vaccine components | |
| IL247185A0 (en) | Tilapia lake virus vaccines | |
| EP3240568A4 (en) | Recombinant influenza virus vaccines for influenza and respiratory syncytial virus | |
| SG11201701279VA (en) | Alkylated influenza vaccines | |
| EP3157950A4 (en) | Influenza vaccines and methods of use thereof | |
| IL249704A0 (en) | Influenza virus vaccines and uses thereof | |
| IL249705B (en) | Influenza virus vaccines and uses thereof | |
| PT3393510T (en) | Zika virus vaccine | |
| TH1501007185A (en) | Viruses and vaccines | |
| GB201408046D0 (en) | Virus preparations |